Lin K, Lipsitz R, Miller T, Janakiraman S: Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med 2008, 149:192–199.
Pinto B, Trunzo J: Health behaviors during and after a cancer diagnosis, cancer survivorship: resilience across the lifespan. Cancer 2005, 104(11 Suppl):2614–2623.
Stein K, Syrjala K, Andrykowski M: Physical and psychological long-term and late effects of cancer. Cancer 2008, 112(11 Suppl):2577–2592.
Bloch S, Love A, Macvean M, et al.: Psychological adjustment of men with prostate cancer: a review of the literature. Biopsychosocial Med 2007, 1:2.
Vitek L, Rosenzweig MQ, Stolling S: Distress in patients with cancer: definition, assessment, and suggested interventions. Clin J Oncol Nurs 2007, 11:413–418.
National Priorities Partnership sets action agenda to improve healthcare and cut waste during time of severe economic strain [press release]. Washington, DC: National Priorities Partnership; November 17, 2008.
Vachon M: The emotional problems of the patient in palliative medicine. In Oxford Textbook of Palliative Medicine. Edited by Doyle D, Hanks G, Cherney N, et al. Oxford: Oxford University Press; 2005:961–985.
Ferrell B, Paice J, Koczywas M: New standards and implications for improving the quality of supportive oncology practice. J Clin Oncol 2008, 26:3824–3831.
Cox J, Amling C: Current decision-making in prostate cancer therapy. Curr Opin Urol 2008, 18:275–278.
Mitchell R, Chang S: Current controversies in the treatment of high-risk prostate cancer. Curr Opin Urol 2008, 18:263–268.
Kunkel E, Bakker J, Myers R, et al.: Biopsychosocial aspects of prostate cancer. Psychosomatics 2000, 41:85–94.
Nelson C, Lee J, Gamboa M, Roth A: Cognitive effects of hormone therapy in men with prostate cancer. Cancer 2008, 5:1097–1106.
DiBlasio CJ, Hammett J, Malcolm JB, et al.: Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Can J Urol 2008, 15:4249–4256.
O’Neill B, Fallon M: ABC of palliative care. Principles of palliative care and pain control. BMJ 1997, 315:801–804.
Brindle LA, Oliver SE, Dedman D, et al.: Measuring the psychological impact of population-based prostate-specific antigen testing for prostate cancer in the UK. BJU Int 2006, 98:777–782.
Shaha M, Cox C, Talman K, Kelly D: Uncertainty in breast, prostate, and colorectal cancer: implications for supportive care. J Nurs Scholarsh 2008, 40:1, 60–67.
Bhatnagar V, Kaplan R: Treatment options for prostate cancer: evaluating the evidence. Am Fam Physician 2005, 71:1915–1922.
Nordin K, Berglund G, Glimelius B, Sjoeeden PO: Predicting anxiety and depression among cancer patients: a clinical model. Eur J Cancer 2001, 37:376–384.
Hinz A, Krauss O, Stolzenburg JU, et al.: Anxiety and depression in patients with prostate cancer and other urogenital cancer: a longitudinal study. Urol Oncol 2008 Apr 25 (Epub ahead of print).
Bisson JI, Chubb HL, Mason M, et al.: The prevalence and predictors of psychological distress in patients with early localized prostate cancer. BJU Int 2002, 90:56–61.
Walker J, Watres R, Murray G, et al.: Better off dead: suicidal thoughts in cancer patients. J Clin Oncol 2008, 26:4725–4730.
Llorente M, Burke M, Gregory G, et al.: Prostate cancer: a significant risk for late-life suicide. Am J Geriatr Psychiatry 2005, 13:195–201.
Reich M: Depression and cancer: recent data on clinical issues, research challenges and treatment approaches. Curr Opin Oncol 2008, 20:353–359.
Kornblith A, Herr HW, Ofman US, et al.: Quality of life of patients with prostate cancer and their spouses. Cancer 1994, 73:2791–2802.
Lawlor PG, Bruera ED: Delirium in patients with advanced cancer. Hematol Oncol Clin North Am 2002, 16:701–714.
Tremont-Lukats I, Bobustuc G, Lagos GK, et al.: Brain metastasis from prostate carcinoma: the M.D. Anderson Cancer Center experience. Cancer 2003, 98:363–368.
Leonard M, Agar M, Mason C, Lawlor P: Delirium issues in palliative care settings. J Psychosom Res 2008, 65:289–298.
Tewari AK, Gold HT, Demers RY, et al.: Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer. Urology 2009, 73:624–630.
Campbell L, Keefe F, Scipio C: Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners. A pilot study of telephone-based coping skills training. Cancer 2007, 109(2 Suppl):414–424.
Jennings D: Love in the time of prostate cancer, prostate cancer journal. New York Times. February 9, 2009. http://well.blogs.nytimes.com/2009/02/09/love-in-the-time-of-prostate-cancer/. Accessed February 20, 2009.
Galbraith M, Arechiga A, Ramirez J, Pedro L: Prostate cancer survivors’ and partners’ self-reports of health-related quality of life, treatment symptoms, and marital satisfaction 2.5–5.5 years after treatment. Oncol Nurs Forum 2005, 2:E30–E41.
Jennings D: Real men get prostate cancer, prostate cancer journal. New York Times. November 18, 2008. http://well.blogs.nytimes.com/2008/11/18/real-men-get-prostate-cancer/. Accessed March 1, 2009.
Kiss A, Meryn S: Effect of sex and gender on psychological aspects of prostate and breast cancer. BMJ 2001, 323:1055–1058.
Carlson L, Speca M, Faris P, Patel K: One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun 2007, 21:1038–1049.